Timeline
Futura Medical
Futura Medical WSD4000 studies show superiority ahead of pivotal trial
Futura Medical signs new US distribution deal with MPG
More in Healthcare
GENinCode genetic test cuts cardiac risk in Catalonia pilot
A real-world pilot by Catalonia's health service found GENinCode's CARDIO inCode-Score reclassified risk in over 40% of moderate-risk patients and drove measurable improvements in cholesterol and smoking cessation.